This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers show that nocturnal heat significantly increases the risk of stroke. The findings can contribute to the development of preventive measures: With them, the population can better protect themselves against the risks of climate change with increasingly frequent hot nights. In addition, knowledge of the consequences of hot nights can improve patient care.
Sivers-Teixeira explains that while the care team should quickly expand once dementia has presented in screening, the primary care role stays consistent.
(MedPage Today) -- Low-dose rivaroxaban (Xarelto), SGLT2 inhibitors, and GLP-1 receptor agonists have entered multisocietal guidelines on peripheral artery disease (PAD) for the first time. (Circulation) Recommendations for postpartum care were.
Cambridge, MA-based artificial intelligence (AI)-driven health technology company, Anumana, has announced its receipt of the International Organization for Standardization (ISO) 13485 certification for its Quality Management System. ECG-AI LEF, the company’s breakthrough AI algorithm, received U.S. Food and Drug Administration (FDA) clearance in September 2023.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
(MedPage Today) -- BOSTON -- Pulsed field ablation (PFA) trials continued to accrue positive data, as reported at the Heart Rhythm Society (HRS) annual meeting. Superiority, Finally Secondary analysis of the pivotal ADVENT trial showed that.
Magnetic resonance imaging (MRI) is increasingly performed each year due to expanding indications, both cardiac and noncardiac, and to enhanced access. The same drivers have increased the use of cardiac implantable electronic devices (CIEDs).
In observational studies, more physical activity was associated with less HFpEF among women and showed a stronger association with reduced mortality than in men.
In observational studies, more physical activity was associated with less HFpEF among women and showed a stronger association with reduced mortality than in men.
Tafamidis, a transthyretin stabilizer, inhibits dissociation of the tetrameric transthyretin protein into monomers, which is the rate-limiting step in amyloidogenesis. Tafamidis was shown in the ATTR-ACT (Transthyretin Amyloidosis Cardiomyopathy Clinical Trial) data.
This analysis may require further research to determine whether other treatment-resistant depression or severe depression definitions are specifically associated with inflammatory joint disease.
Alkhouri explains survodutide’s mechanism of action as a glucagon/GLP-1 receptor dual agonist and reviews key findings about its use in MASH from the interim analysis.
This cohort study evaluates mortality and morbidity outcomes among patients undergoing transcatheter or surgical replacement for failed bioprosthetic aortic valves.
The goal of the INTERACT4 trial was to determine the effect of prehospital treatment of elevated systolic blood pressure (SBP) in patients with recent onset of symptoms concerning for acute stroke.
This randomized clinical trial investigates which strategy is more effective in patients with atrial fibrillation and obesity: dual or single direct-current cardioversion.
Despite the existence of several Randomized Controlled Trials (RCTs) investigating Low-Dose Computed Tomography (LDCT) as a guide in lung biopsies, conclusive findings remain elusive. To address this contentio.
A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight. Image courtesy: Hello Heart christine.book Tue, 05/21/2024 - 23:22 May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association , JAHA , found that Hello Heart’s digital heart
Hereditary transthyretin amyloid (ATTRv) cardiomyopathy (CM) is caused by mutations in the TTR gene. TTR mutations contribute to TTR tetramer destabilization and dissociation, leading to excessive deposition of insoluble amyloid fibrils in the myocardium and finally resulting in cardiac dysfunction. In this article, we report a case of a Chinese patient with transthyretin mutation p.D58Y and provide detailed information on cardiac amyloidosis, including transthoracic echocardiography, cardiac ma
BackgroundTransplant renal artery dissection (TRAD) is a rare and serious event that can cause allograft dysfunction and eventually graft loss. Most cases are managed by operative repair. We report a case of TRAD in the early postoperative period, which was successfully managed with intravascular ultrasound-assisted endovascular intervention.Case presentationA 38-year-old man underwent HLA-compatible living kidney transplantation.
milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024 , scheduled to take place during Heart Rhythm Society Scientific Sessions in Boston, Massachusetts. Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablat
Publication date: Available online 20 May 2024 Source: The American Journal of Cardiology Author(s): Marsioleda Kemberi, Eduardo Urgesi, Ji ngYong Ng, Kush Patel, Mohammed Y Khanji, Wael I Awad
Publication date: Available online 20 May 2024 Source: The American Journal of Cardiology Author(s): Shaye Kivity, Tomer Ziv Baran, Miri Mizrahi Reuveni, Angela Irony, Limor Adler, Yehuda Alder, Roma Parikh, Sara Kivity
Coronary microvascular disease (CMVD) is common in patients with cardiovascular risk factors and is linked to an elevated risk of adverse cardiovascular events. Although modern medicine has made significant strides in researching CMVD, we still lack a comprehensive understanding of its pathophysiological mechanisms due to its complex and somewhat cryptic etiology.
A cable-transmission magnetically controlled capsule endoscopy showed comparability to conventional methods in upper GI tract examinations and lesion detection.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content